Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Although genetic factors contribute to almost half of all cases of deafness, treatment options for genetic deafness are limited. We developed a genome-editing approach to target a dominantly inherited form of genetic deafness. Here we show that cationic lipid-mediated in vivo delivery of Cas9-guide RNA complexes can ameliorate hearing loss in a mouse model of human genetic deafness. We designed and validated, both in vitro and in primary fibroblasts, genome editing agents that preferentially disrupt the dominant deafness-associated allele in the Tmc1 (transmembrane channel-like gene family 1) Beethoven (Bth) mouse model, even though the mutant Tmc1 Bth allele differs from the wild-type allele at only a single base pair. Injection of Cas9-guide RNA-lipid complexes targeting the Tmc1 Bth allele into the cochlea of neonatal Tmc1 Bth/+ mice substantially reduced progressive hearing loss. We observed higher hair cell survival rates and lower auditory brainstem response thresholds in injected ears than in uninjected ears or ears injected with control complexes that targeted an unrelated gene. Enhanced acoustic startle responses were observed among injected compared to uninjected Tmc1 Bth/+ mice. These findings suggest that protein-RNA complex delivery of target gene-disrupting agents in vivo is a potential strategy for the treatment of some types of autosomal-dominant hearing loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“For example, lipid-mediated nanoparticle (LNP) delivery has been used to transport CRISPR-Cas components in the form of either mRNA/sgRNA or preassembled RNPs into tissues 71-74 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [74]
In the citing paper
“Additionally, lower auditory response thresholds and improved acoustic responses were observed in injected mice.[226]”
From RNA delivery biomaterials for the treatment of genetic and rare diseases (2019) · cites this paper as [226]
In the citing paper
“The intraaural injection of Cas9 RNPs/lipofectamine 2000 complexes into the scala media of neonatal Tmc1Bth/+ mice significantly increased the survival of hair cells.”
From RNA delivery biomaterials for the treatment of genetic and rare diseases (2019) · cites this paper as [226]
In the citing paper
“All these results demonstrated that this system substantially reduced progressive hearing loss in Beethoven mouse model (Fig. 3B) [113].”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [113]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268 · cited 4×
“We identified three candidate sgRNAs (Tmc1-mut1, Tmc1-mut2, and Tmc1-mut3) that place the Bth mutation at position 11, 12, or 15, respectively, of the spacer, counting the PAM as positions 21-23 (Fig.”
InfluentialImproving CRISPR-Cas nuclease specificity using truncated guide RNAs
Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2808 · Cited by 1,993 · cited 1×
“A fourth sgRNA, Tmc1-mut4, is a truncated version of Tmc1-mut3 designed to increase genome editing DNA specificity 22 .”
Kim, S., Kim, D., Cho, S. W., Kim, J., & Kim, J.-S. (2014) · Genome Research · doi:10.1101/gr.171322.113 · Cited by 1,856
Newborn Hearing Screening — A Silent Revolution
Morton, C. C., & Nance, W. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmra050700 · Cited by 1,686
Pattanayak, V., Lin, S., Guilinger, J. P., Ma, E., Doudna, J. A., & Liu, D. R. (2013) · Nature Biotechnology · doi:10.1038/nbt.2673 · Cited by 1,487
Self-citationZuris, J. A., Thompson, D. B., Shu, Y., Guilinger, J. P., Bessen, J. L., Hu, J. H., Maeder, M. L., Joung, J. K., Chen, Z.-Y., & Liu, D. R. (2015) · Nature Biotechnology · doi:10.1038/nbt.3081 · Cited by 1,460
Self-citationCRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
Komor, A. C., Badran, A. H., & Liu, D. R. (2017) · Cell · doi:10.1016/j.cell.2016.10.044 · Cited by 1,013
Self-citationLong, C., Amoasii, L., Mireault, A. A., McAnally, J. R., Li, H., Sanchez-Ortiz, E., Bhattacharyya, S., Shelton, J. M., Bassel-Duby, R., & Olson, E. N. (2016) · Science · doi:10.1126/science.aad5725 · Cited by 937
Yin, H., Song, C.-Q., Dorkin, J. R., Zhu, L. J., Li, Y., Wu, Q., Park, A., Yang, J., Suresh, S., Bizhanova, A., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3471 · Cited by 876
Self-citationEfficient delivery of genome-editing proteins using bioreducible lipid nanoparticles
Wang, M., Zuris, J. A., Meng, F., Rees, H., Sun, S., Deng, P., Han, Y., Gao, X., Pouli, D., Wu, Q., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520244113 · Cited by 624
Self-citation
Cited by
Items 301–400 of 566
Xiao, Y., Chen, L., Xu, K., Zhou, M., Han, Y., Luo, J., Ai, Y., Wang, M., Jin, Y., Qiao, R., et al. (2024) · Human Genetics · doi:10.1007/s00439-024-02694-x · Cited by 16
Self-citationGene therapy: an emerging therapy for hair cells regeneration in the cochlea
Wang, J., Zheng, J., Wang, H., He, H., Li, S., Zhang, Y., Wang, Y., Xu, X., & Wang, S. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1177791 · Cited by 16
Self-citationYao, J. T., Wang, Y., Cao, C., Song, R., Bi, D., Zhang, H., Li, Y., Qin, G., Hou, N., Zhang, N., et al. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.04.009 · Cited by 16
Self-citationBian, X., Yu, X., Lu, S., Jia, L., Li, P., Yin, J., & Tan, S. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.137708 · Cited by 16
Recent advances in CRISPR research
Chen, B., Niu, Y., Wang, H., Wang, K., Yang, H., & Li, W. (2020) · Protein & Cell · doi:10.1007/s13238-020-00704-y · Cited by 16
Self-citationUnlocking mRNA-driven CRISPR-Cas9 gene therapy via optimizing mRNA and the delivery vectors
Wang, S., Xu, X., Viitala, T., Shu, Y., & Zhang, H. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102737 · Cited by 15
Self-citationPolley, D. B., & Schiller, D. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104652 · Cited by 15
Self-citationYu, W., Hill, S. F., Huang, Y., Zhu, L., Demetriou, Y., Ziobro, J. M., Reger, F., Jia, X., Mattis, J., & Meisler, M. H. (2024) · Annals of Neurology · doi:10.1002/ana.27053 · Cited by 15
Specific Targeting of Oncogenes Using CRISPR Technology
Oppel, F., Schürmann, M., Goon, P. K. C., Albers, A. E., & Sudhoff, H. H. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0571 · Cited by 15
Leclere, J.-C., Marianowski, R., & Montier, T. (2024) · Hearing Research · doi:10.1016/j.heares.2024.109130 · Cited by 15
Animal model studies yield translational solutions for cochlear drug delivery
Frisina, R. D., Budzevich, M. M., Zhu, X., Martinez, G. V., Walton, J. P., & Borkholder, D. A. (2018) · Hearing Research · doi:10.1016/j.heares.2018.05.002 · Cited by 15
Simons, E. J., & Trapani, I. (2023) · Human Gene Therapy · doi:10.1089/hum.2023.126 · Cited by 14
“2 Two studies targeting mouse Tmc1 , one using a liposome vector 49 and other using AAVAnc80, 50 demonstrated partial preservation of hearing.”
CRISPR/Cas systems usher in a new era of disease treatment and diagnosis
Li, R., Wang, Q., She, K., Lu, F., & Yang, Y. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00095-y · Cited by 14
Delivery of gene editing therapeutics
Kevadiya, B. D., Islam, F. S., Deol, P., Zaman, L. A., Mosselhy, D. A., Ashaduzzaman, M., Bajwa, N., Routhu, N. K., Singh, P. A., Dawre, S., et al. (2023) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2023.102711 · Cited by 14
Recent preclinical and clinical advances in gene therapy for hereditary hearing loss
Jang, S. H., Song, H. G., Jung, J., & Gee, H. Y. (2025) · Molecules and Cells · doi:10.1016/j.mocell.2025.100285 · Cited by 14
Emerging therapies for human hearing loss
Ajay, E. A., Gunewardene, N., & Richardson, R. T. (2022) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2072208 · Cited by 14
How Crisp is CRISPR? CRISPR-Cas-mediated crop improvement with special focus on nutritional traits
Kaul, T., Sony, S. K., Raman, N. M., Eswaran, M., Verma, R., Prakash, A. T., Bharti, J., Motelb, K. F. A., & Kaul, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818581-0.00011-5 · Cited by 14
Altering gene expression using antisense oligonucleotide therapy for hearing loss
Robillard, K. N., de Vrieze, E., van Wijk, E., & Lentz, J. J. (2022) · Hearing Research · doi:10.1016/j.heares.2022.108523 · Cited by 14
Mutation-agnostic RNA interference with engineered replacement rescuesTmc1-related hearing loss
Iwasa, Y.-I., Klimara, M. J., Yoshimura, H., Walls, W. D., Omichi, R., West, C., Shibata, S. B., Ranum, P. T., & Smith, R. J. (2022) · Life Science Alliance · doi:10.26508/lsa.202201592 · Cited by 14
Billon, P., Nambiar, T. S., Hayward, S. B., Zafra, M. P., Schatoff, E. M., Oshima, K., Dunbar, A. J., Breinig, M., Park, Y. C., Ryu, H.-S., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.068 · Cited by 14
Canalostomy is an ideal surgery route for inner ear gene delivery in big animal model
Ji, X., Chen, W., Wang, X., Zhang, Y., Liu, Q., Guo, W., Zhao, J., & Yang, S. (2019) · Acta Oto-Laryngologica · doi:10.1080/00016489.2019.1654130 · Cited by 14
Self-citationMolecular therapy for genetic and degenerative vestibular disorders
Sayyid, Z. N., Kim, G. S., & Cheng, A. G.-L. (2018) · Current Opinion in Otolaryngology & Head & Neck Surgery · doi:10.1097/moo.0000000000000477 · Cited by 14
White, P. M. (2020) · Brain Sciences · doi:10.3390/brainsci10100756 · Cited by 13
Precise Gene Knock‐In Tools with Minimized Risk of DSBs: A Trend for Gene Manipulation
Liu, Y. H., Kong, J., Liu, G., Li, Z., & Xiao, Y. (2024) · Advanced Science · doi:10.1002/advs.202401797 · Cited by 13
Programas de cribado de la hipoacusia congénita en 2020: recomendaciones CODEPEH
Núñez-Batalla, F., Jáudenes-Casaubón, C., Canet, J. M. S., Vivanco-Allende, A., Zubicaray-Ugarteche, J., & Lascarro, I. O. (2020) · Acta Otorrinolaringológica Española · doi:10.1016/j.otorri.2020.06.009 · Cited by 13
Zheng, Q., Wang, W., Zhou, Y., Mo, J., Chang, X., Zha, Z., & Zha, L. (2023) · Biomaterials Science · doi:10.1039/d3bm00788j · Cited by 12
Recent advances and future prospects in direct cardiac reprogramming
Xie, Y., Handel, B. V., Li, Q., & Ardehali, R. (2023) · Nature Cardiovascular Research · doi:10.1038/s44161-023-00377-w · Cited by 12
NOX2 Contributes to High‐Frequency Outer Hair Cell Vulnerability in the Cochlea
Qi, M., Gao, Z., Qiu, Y., Wang, R., Tian, K., Yue, B., Zhang, X., Zhang, P., Wu, Z., Zhu, Q., et al. (2025) · Advanced Science · doi:10.1002/advs.202408830 · Cited by 12
Wang, J., Chen, R., & Lu, F. (2019) · PubMed Central · doi:10.3760/cma.j.issn.1007-3418.2019.08.005 · Cited by 12
Iron‐Confined CRISPR/Cas9‐Ribonucleoprotein Delivery System for Redox‐Responsive Gene Editing
Qiu, L., Sun, M., Chen, L., Jiang, J., Fu, Z., Wang, Y., Bi, Y., Guo, Q., Bai, H., Chen, S., et al. (2024) · Small · doi:10.1002/smll.202309431 · Cited by 12
Graceffa, V. (2023) · Biochimie · doi:10.1016/j.biochi.2023.05.011 · Cited by 12
Stem Cells: A New Hope for Hearing Loss Therapy
Qiu, Y., & Qiu, J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-6123-4_10 · Cited by 12
Gene therapy for genetic mutations affecting non-sensory cells in the cochlea
Zhang, L., Wu, X., & Lin, X. (2019) · Hearing Research · doi:10.1016/j.heares.2019.107858 · Cited by 12
Reversal of an existing hearing loss by gene activation in Spns2 mutant mice
Martelletti, E., Ingham, N. J., & Steel, K. P. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2307355120 · Cited by 12
Núñez-Batalla, F., Casaubón, C. J., Canet, J. M. S., Allende, A. V., Ugarteche, J. Z., & Lascarro, I. O. (2020) · Revista Española de Discapacidad · doi:10.5569/2340-5104.08.01.13 · Cited by 12
Cho, S. H., Yun, Y., Lee, D. H., Hyun, J., Lee, S. M., Lee, J., Suh, M., Lee, J. H., Oh, S.-H., Park, M. K., et al. (2023) · BMC Medical Genomics · doi:10.1186/s12920-023-01766-7 · Cited by 11
Jackler, R. K., & Jan, T. A. (2019) · The Journal of Laryngology & Otology · doi:10.1017/s0022215119001531 · Cited by 11
Forward genetic approach for behavioral neuroscience using animal models
Funato, H. (2020) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.96.002 · Cited by 11
Genetics Matters: Voyaging from the Past into the Future of Humanity and Sustainability
Cheng, A., Harikrishna, J. A., Redwood, C. S., Lit, L. C., Nath, S. K., & Chua, K. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073976 · Cited by 11
Callegari, A., Kueblbeck, M., Morero, N. R., Serrano‐Solano, B., & Ellenberg, J. (2024) · Nature Protocols · doi:10.1038/s41596-024-01043-6 · Cited by 11
Gene therapy development in hearing research in China
Zhang, Z., Wang, J., Li, C., Xue, W., Xing, Y., & Liu, F. (2020) · Gene Therapy · doi:10.1038/s41434-020-0177-1 · Cited by 11
Saponin and fluorine-modified polycation as a versatile gene delivery system
Hasanzadeh, A., Vahabi, A. H., Hooshmand, S. E., Hosseini, E. S., Azar, B. K. Y., Kiani, J., Saeedi, S., Shahbazi, A., Rudra, A., Hamblin, M. R., et al. (2022) · Nanotechnology · doi:10.1088/1361-6528/ac842d · Cited by 11
Verdoodt, D., Peeleman, N., Camp, G. V., Rompaey, V. V., & Ponsaerts, P. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.728610 · Cited by 11
Precision medicine: a new era for inner ear diseases
Tavazzani, E., Spaiardi, P., Contini, D., Sancini, G., Russo, G., & Masetto, S. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1328460 · Cited by 11
New-born Hearing Screening Programmes in 2020: CODEPEH Recommendations
Núñez-Batalla, F., Jáudenes-Casaubón, C., Canet, J. M. S., Vivanco-Allende, A., Zubicaray-Ugarteche, J., & Lascarro, I. O. (2021) · Acta Otorrinolaringologica (English Edition) · doi:10.1016/j.otoeng.2020.06.009 · Cited by 11
Updates on Genetic Hearing Loss: From Diagnosis to Targeted Therapies
Yun, Y., & Lee, S. (2024) · Journal of Audiology & Otology · doi:10.7874/jao.2024.00157 · Cited by 10
Öktem, M., Nguyen, T. H., Bosman, E., Fens, M. H. A. M., Caiazzo, M., Mastrobattista, E., Lei, Z., & de Jong, O. G. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113854 · Cited by 10
Regenerative Therapy Approaches and Encountered Problems in Sensorineural Hearing Loss
Kelleci, K., & Gölebatmaz, E. (2022) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x17666220429121714 · Cited by 10
Pendse, N. D., Lamas, V., Maeder, M. L., Pawlyk, B. S., Gloskowski, S. W., Pierce, E. A., Chen, Z., & Liu, Q. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.04.934240 · Cited by 10
Self-citationGene therapy for hereditary hearing loss
Fu, Z., Zhao, L., Guo, Y., & Yang, J. (2024) · Hearing Research · doi:10.1016/j.heares.2024.109151 · Cited by 10
Recent progress on the CRISPR/Cas system in optical biosensors
Li, B., Zhai, G., Dong, Y., Wang, L., & Ma, P. (2024) · Analytical Methods · doi:10.1039/d3ay02147e · Cited by 10
Gene therapy advancements for the treatment of acquired and hereditary hearing loss
Duhon, B. H., Bielefeld, E. C., Ren, Y., & Naidoo, J. (2024) · Frontiers in Audiology and Otology · doi:10.3389/fauot.2024.1423853 · Cited by 10
Nuclear‐Targeting Peptides for Cancer Therapy
Yi, X., Hussaın, I., Zhang, P., & Xiao, C. (2024) · ChemBioChem · doi:10.1002/cbic.202400596 · Cited by 10
CRISPR: a promising tool for lipid physiology and therapeutics
Furgurson, M. N., & Lagor, W. R. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000591 · Cited by 10
Contemporary directions in the therapy of sensory hearing loss
Rzepakowska, A., Borowy, A., Siedlecki, E., Wolszczak, M., & Radomska, K. J. (2024) · Otolaryngologia Polska · doi:10.5604/01.3001.0054.5439 · Cited by 10
Chen, J., Su, S., Pickar‐Oliver, A., Chiarella, A. M., Hahn, Q., Goldfarb, D., Cloer, E. W., Small, G. W., Sivashankar, S., Ramsden, D. A., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae761 · Cited by 9
Update on Gene Therapy in the Treatment of Hereditary Hearing Loss
He, W., Han, S., Liu, X., Huang, X., Yang, W., Tang, X., Dong, C., & Fan, J. (2025) · Sensory Neuroscience · doi:10.1002/sen2.70004 · Cited by 9
Recent advances in CRISPR-Cas system for the treatment of genetic hearing loss.
Yin, G., Wang, X., & Sun, Y. (2023) · PubMed Central · Cited by 9
Mechanism of action and treatment of type I interferon in hepatocellular carcinoma
Peng, C., Ye, Z., Ju, Y., Huang, X., Zhan, C., Wei, K., & Zhang, Z. (2023) · Clinical & Translational Oncology · doi:10.1007/s12094-023-03266-7 · Cited by 9
The Reconstruction of Peripheral Auditory Circuit: Recent Advances and Future Challenges
Li, Z., Zhang, Y., Xiao, Z., & Qi, J. (2025) · Advanced Science · doi:10.1002/advs.202410494 · Cited by 9
Wei, W., Zhu, W., Silver, S., Armstrong, A. M., Robbins, F. S., Rameshbabu, A. P., Walz, K., Quan, Y., Du, W., Kim, Y., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci187872 · Cited by 9
Self-citationTsuji, T., Imada, Y., Yamazaki, H., & Kawano, S. (2019) · Sensors and Actuators A Physical · doi:10.1016/j.sna.2019.05.043 · Cited by 9
Sensory transduction in auditory hair cells—PIEZOs can’t touch this
Holt, J. R., Fettiplace, R., & Müller, U. (2024) · The Journal of General Physiology · doi:10.1085/jgp.202413585 · Cited by 9
Self-citationMechanistic machine learning for prediction of prime editing outcomes
Hsu, A., Chen, P. J., Li, A. H., Hemez, C. F., Gao, X. D., Terrey, M., Nelson, C., Selvam, V., Cristian, A., McElroy, A. N., et al. (2026) · Nature Biotechnology · doi:10.1038/s41587-026-03261-7 · Cited by 8
Self-citationG protein-coupled receptors in cochlea: Potential therapeutic targets for hearing loss
Ma, X., Guo, J., Fu, Y., Shen, C., Jiang, P., Zhang, Y., Zhang, L., Yu, Y., Fan, J., & Chai, R. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1028125 · Cited by 8
Vitry, S., Mendia, C., Maudoux, A., & El-Amraoui, A. (2025) · Mammalian Genome · doi:10.1007/s00335-025-10126-y · Cited by 8
Toward In Vivo Gene Therapy Using CRISPR
Skipper, K. A., & Mikkelsen, J. G. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9170-9_18 · Cited by 8
Genome Editing in Dyslipidemia and Atherosclerosis
Chen, Z., Lehertshuber, C., & Schunkert, H. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-5642-3_10 · Cited by 8
Self-citationAutosomal Recessive Non-Syndromic Deafness: Is AAV Gene Therapy a Real Chance?
Brotto, D., Greggio, M., de Filippis, C., & Trevisi, P. (2024) · Audiology Research · doi:10.3390/audiolres14020022 · Cited by 8
Challenges and advances in translating gene therapy for hearing disorders
Büning, H., Schambach, A., Morgan, M. A., Rossi, A., Wichova, H., Staecker, H., Warnecke, A., & Lenarz, T. (2020) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2020.1707077 · Cited by 8
Clinical gene therapy restores hearing: a paradigm shift
Han, S., Chen, Z., Wang, D., Jiang, L., Fan, X., Zhong, J., Cui, C., Chen, Y., lv, J., Zhang, J., et al. (2025) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2025.07.007 · Cited by 8
Self-citationEngineering of a high-fidelity Cas12a nuclease variant capable of allele-specific editing
Wei, J., Liu, J., Wang, Z., Yang, Y., Tian, Y., Wang, S., Gao, B., Gao, S., Li, Y., Tang, J., et al. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002680 · Cited by 8
Self-citationFunctional cargo delivery into mouse and human fibroblasts using a versatile microfluidic device
Lam, K. H., Fernandez-Perez, A., Schmidtke, D. W., & Munshi, N. V. (2018) · Biomedical Microdevices · doi:10.1007/s10544-018-0292-6 · Cited by 8
Wang, H., Wu, K., Guan, J., & Wang, Q. (2020) · Stem Cell Research · doi:10.1016/j.scr.2020.101982 · Cited by 8
Self-citationVázquez-Domínguez, I., Öktem, M., Winkelaar, F. A., Nguyen, T. H., Hoogendoorn, A. D. M., Roschi, E., Astuti, G., Timmermans, R., Suárez-Herrera, N., Bruno, I., et al. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102345 · Cited by 7
The applications of targeted delivery for gene therapies in hearing loss
Jones, M., Kovačević, B., Ionescu, C. M., Wagle, S. R., Quintas, C., Wong, E. Y. M., Mikov, M., Mooranian, A., & Al‐Salami, H. (2023) · Journal of drug targeting · doi:10.1080/1061186x.2023.2216900 · Cited by 7
Nam, Y. S., Choi, Y. M., Lee, S., & Cho, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065695 · Cited by 7
Gene therapy as a possible option to treat hereditary hearing loss
Morgan, M. A., Schott, J. W., Rossi, A., Landgraf, C., Warnecke, A., Staecker, H., Lesinski‐Schiedat, A., Schlegelberger, B., Büning, H., Auber, B., et al. (2020) · Medizinische Genetik · doi:10.1515/medgen-2020-2021 · Cited by 7
Endoplasmic reticulum stress as target for treatment of hearing loss
Wang, Y., & Xu, Z. (2020) · STEMedicine · doi:10.37175/stemedicine.v1i3.21 · Cited by 7
Discovery and engineering of ChCas12b for precise genome editing
Wei, J., Liu, J., Tian, Y., Wang, Z., Hou, L., Yang, Y., Tao, C., Li, M., Gao, B., Zhou, H., et al. (2024) · 中国科学通报:英文版 · doi:10.1016/j.scib.2024.06.012 · Cited by 7
Intracellular Delivery of Proteins into Living Cells by Low-Molecular-Weight Polyethyleneimine
Wu, Y., jiang, L., Dong, Z., Chen, S., Yu, X., & Tang, S. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s315444 · Cited by 7
Qiu, Y., Wang, H., Pan, H., Ding, X., Guan, J., Zhuang, Q., Wu, K., Lei, Z., Cai, H., Dong, Y., et al. (2023) · Hearing Research · doi:10.1016/j.heares.2023.108919 · Cited by 7
Self-citationNúñez-Batalla, F., Casaubón, C. J., Canet, J. M. S., Allende, A. V., & Ugarteche, J. Z. (2019) · Revista Española de Discapacidad · doi:10.5569/2340-5104.07.01.10 · Cited by 7
Meng, B., Qu, Y., Yang, B., Fu, C., He, Y., Li, J., Wan, R., Li, X., Xue, Z., Cao, Z., et al. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01584-5 · Cited by 6
Tisi, A., Palaniappan, S., & Maccarrone, M. (2023) · Biomolecules · doi:10.3390/biom13101534 · Cited by 6
In vivo gene therapy: A strategy for mutations, degenerations, and tumors
Wang, T., Yu, M., Liu, P., Song, Z., Li, C., Yang, J., & Liu, N. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101808 · Cited by 6
CRISPR–Cas Gene Editing for Neurological Disease
Simpson, B. P., & Davidson, B. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813997-4.00018-9 · Cited by 6
Nanotechnology-enhanced gene therapy for hearing loss
Liu, Y., Li, L., Huang, P., Zha, D., & Deng, H. (2025) · Nanoscale Horizons · doi:10.1039/d5nh00520e · Cited by 6
Induced Pluripotent Stem Cells, a Stepping Stone to In Vitro Human Models of Hearing Loss
Alonso, M. B. D., & Petković, H. (2022) · Cells · doi:10.3390/cells11203331 · Cited by 6
Polymer‐Based Nanoparticles for Inner Ear Targeted Trans Differentiation Gene Therapy
Foster, T., Lim, P., Jones, M., Wagle, S. R., Kovačević, B., Ionescu, C. M., Wong, E. Y. M., Mooranian, A., & Al‐Salami, H. (2024) · ChemMedChem · doi:10.1002/cmdc.202400038 · Cited by 6
Jimenez, J. E., Nourbakhsh, A., Colbert, B., Mittal, R., Yan, D. L. S., Green, C. L., Nisenbaum, E. S., Liu, C., Bencie, N., Rudman, J. R., et al. (2020) · Gene · doi:10.1016/j.gene.2020.144677 · Cited by 6
Noh, B., Gopalappa, R., Lin, H., Gee, H. Y., Choi, J. Y., Kim, S., & Jung, J. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.08.049 · Cited by 6
Chitosan and Their Nanocomposites for Biomedical Applications
Sharma, D. K., Pattnaik, G., Moharana, S., & Behera, A. (2024) · Springer series on polymer and composite materials · doi:10.1007/978-3-031-69654-1_11 · Cited by 6
Exploring delivery systems for targeted nanotechnology-based gene therapy in the inner ear
Foster, T., Lim, P., Ionescu, C. M., Wagle, S. R., Kovačević, B., Mooranian, A., & Al‐Salami, H. (2024) · Therapeutic Delivery · doi:10.1080/20415990.2024.2389032 · Cited by 6
Transcript Profiles of Stria Vascularis in Models of Waardenburg Syndrome
Chen, L., Wang, L., Chen, L., Wang, F., Ji, F., Sun, W., Zhao, H., Han, W., & Yang, S. (2020) · Neural Plasticity · doi:10.1155/2020/2908182 · Cited by 6
Self-citationGenetics of pediatric hearing loss: A functional perspective
Khela, H. S., & Kenna, M. A. (2020) · Laryngoscope Investigative Otolaryngology · doi:10.1002/lio2.390 · Cited by 6
Wang, H., Luo, Y., Li, J., Guan, J., Yang, S., & Wang, Q. (2022) · Stem Cell Research · doi:10.1016/j.scr.2022.102736 · Cited by 6
Self-citationRompaey, V. V. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00290 · Cited by 6
Gene modification: Exploring the potential in treating kidney diseases
Ekperikpe, U. S., Zhao, S., & Daehn, I. S. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108104 · Cited by 5
The applications of CRISPR/Cas-mediated genome editing in genetic hearing loss
Wu, J., Tao, Y., Deng, D., Meng, Z., & Zhao, Y. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01021-7 · Cited by 5
Self-citation
Metadata
- Authors
- Gao, X., Tao, Y., Lamas, V., Huang, M., Yeh, W.-H., Pan, B., Hu, Y.-J., Hu, J. H., Thompson, D. B., Shu, Y., Li, Y., Wang, H., Yang, S., Xu, Q., Polley, D. B., Liberman, M. C., Kong, W.-J., Holt, J. R., Chen, Z.-Y., & Liu, D. R.
- Affiliations
- Broad Institute (US)
- Massachusetts Eye and Ear Infirmary (US)
- Boston Children's Hospital (US)
- Howard Hughes Medical Institute (US)
- Tufts University (US)
- Corresponding author
- Chen, Zheng-Yi
- Liu, David R.
- ORCID
- Venue
- Nature
- Published
- 2017-12-20
- Volume
- 553
- Issue
- 7687
- Pages
- 217-221
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5784267
- OpenAlex
- W2778806019
- Cited by
- 536
- References
- 28
- Citations by year
- 2026: 25 · 2025: 43 · 2024: 58 · 2023: 62 · 2022: 64 · 2021: 60 · 2020: 101 · 2019: 67 · 2018: 54 · 2017: 1
- FWCI
- 37.88
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (2r01dc013521-11a1)
- National Institute on Deafness and Other Communication Disorders (R01-DC013521, R01DC009836, P30DC005209, R01DC006908, F32DC000138, R01DC000188)
- National Institute of General Medical Sciences (R35GM118062)
- National Institute of Biomedical Imaging and Bioengineering (R01EB022376)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD090255)
- Topics
- Life Sciences › Neuroscience › Sensory Systems › Hearing, Cochlea, Tinnitus, Genetics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- autosomal dominant hearing loss, CRISPR/Cas9 genome editing, in vivo gene delivery, dominant negative mutation, auditory brainstem response, acoustic startle response
- MeSH terms
- Gene Editing, Acoustic Stimulation, Alleles, Animals, Animals, Newborn, Auditory Threshold, Base Sequence, Cell Survival, Cochlea, Disease Models, Animal, Female, Fibroblasts, Genes, Dominant, Hair Cells, Auditory, Humans, Liposomes, Male, Membrane Proteins, Reflex, Startle, Genetic Therapy, Evoked Potentials, Auditory, Brain Stem, Hearing Loss, Mice, CRISPR-Cas Systems, CRISPR-Associated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.